April 22, 2008 - Balancing evidence-based medicine and point-of-care testing for improved supervision efficiency and patient satisfaction, with time constraints, complex care networks and complicated trial findings hinder success will be discussed at "Managing CVD," a seminar for internists, to be held on May 14, 2008, at the Renaissance Grand Ballroom North in Washington, DC.
The continuing medical education (CME) program includes a review of the most current clinical information for overseeing hypertensive patient care given by Michael J. Bloch, MD, Associate Professor, Internal Medicine and Cardiology, University of Nevada School of Medicine, and Medical Director, St. Mary's Risk Reduction Center, Reno.
The program will also address internists with a fresh grasp of heart failure in association with obesity, hypertension and coronary artery disease as well as anticoagulant initiatives.
"The key lesson of recent cholesterol clinical trials is only partly that we should be treating to lower LDL targets; as important is evaluating a variety of different non-lipid risk factors in determining patients appropriate for medical therapy," said one of the speakers, Benjamin J. Ansell, M.D., FACP, FACC, associate professor, Medicine/Cardiology, and co-director, Cholesterol, Hypertension and Atherosclerosis Management Program, UCLA David Geffen School of Medicine.
For more information: www.medavera.com and www.managingcvd.com
June 19, 2024 
